Clinical trial
A Protocol of a Randomised, Two-arm Superiority Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
NCT07484633 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Protocol of a Randomised, Two-arm Superiority Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
- Lead sponsor
- Semmelweis University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- April 30, 2026
- Completion date
- April 30, 2028
- Enrollment
- 110 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
beta lactams, infection, nicu, picu, sepsis